elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37403891-1812456F-E12F-4B85-BB91-5F46893F03BA
Q37403891-1812456F-E12F-4B85-BB91-5F46893F03BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37403891-1812456F-E12F-4B85-BB91-5F46893F03BA
In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer.
P2860
Q37403891-1812456F-E12F-4B85-BB91-5F46893F03BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37403891-1812456F-E12F-4B85-BB91-5F46893F03BA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a92d11772e7cc1e62e0928b5999c505330d2430a
P2860
The effects of four different tyrosine kinase inhibitors on medullary and papillary thyroid cancer cells.